​

Editas Medicine Ownership | Who Owns Editas Medicine?

OverviewForecastRevenueFinancialsChart

Editas Medicine Ownership Summary

Editas Medicine is owned by 122.77% institutional investors, 0.18% insiders. Tcg crossover management is the largest institutional shareholder, holding 11.35% of EDIT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Editas Medicine shares.

EDIT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEditas Medicine122.77%0.18%-22.95%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tcg crossover management11.11M11.35%$36.00M
Blackrock funding, inc. /de10.59M10.82%$34.31M
Blackrock7.78M9.50%$36.34M
Vanguard group8.21M9.11%$16.83M
Ra capital management8.89M9.08%$28.80M
Adar1 capital management8.89M9.08%$28.80M
Commodore capital lp8.89M9.08%$28.80M
Vanguard capital management6.14M6.27%$19.90M
Paradigm biocapital advisors lp5.59M5.71%$18.10M
Opaleye management3.86M3.95%$12.51M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp8.89M1.72%$28.80M
Adar1 capital management8.89M1.32%$28.80M
Opaleye management3.86M1.13%$12.51M
Vivo capital3.56M1.05%$11.52M
Tcg crossover management11.11M0.87%$36.00M
Green alpha advisors156.05K0.34%$505.59K
Paradigm biocapital advisors lp5.59M0.34%$18.10M
Logos global management lp2.22M0.31%$7.20M
Ra capital management8.89M0.25%$28.80M
Dafna capital management170.47K0.11%$552.32K

Top Buyers

HolderShares% AssetsChange
Tcg crossover management11.11M0.87%11.11M
Adar1 capital management8.89M1.32%8.89M
Commodore capital lp8.89M1.72%8.89M
Ra capital management8.89M0.25%8.89M
Paradigm biocapital advisors lp5.59M0.34%5.59M

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---4.90M
Renaissance2.47M0.01%-1.50M
Avidity partners management lp---1.47M
Nuveen521.21K0.00%-1.46M
Pictet asset management sa---1.16M

New Positions

HolderShares% AssetsChangeValue
Tcg crossover management11.11M0.87%11.11M$36.00M
Ra capital management8.89M0.25%8.89M$28.80M
Commodore capital lp8.89M1.72%8.89M$28.80M
Adar1 capital management8.89M1.32%8.89M$28.80M
Paradigm biocapital advisors lp5.59M0.34%5.59M$18.10M

Sold Out

HolderChange
Gps wealth strategies group-2.00
Pacific capital wealth advisors-5.00
Sittner & nelson-6.00
Quintet private bank (europe)-6.00
Baldwin brothers llc/ma-8.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262212.79%120,168,106131.67%1223.59%11313.00%40-14.89%
Mar 31, 2026151-25.98%34,771,706-30.36%391.28%69-8.00%27-54.24%
Dec 31, 2025163-20.87%39,288,742-8.85%431.67%54-28.00%48-17.24%
Sep 30, 2025197-43,075,9754.21%512.13%69-9.21%5711.76%
Jun 30, 2025191-3.54%41,244,466-6.30%481.74%72-52-8.77%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.89M3.19%-
Vanguard Morn Total Stk Mkt Idx Investor4.89M3.19%-
Vanguard US Total Market Shares ETF2.59M3.12%-
iShares Russell 2000 ETF2.58M1.68%-45.79K
Pictet Biopharmaceutical Mother1.15M1.38%42.67K
Vanguard Strategic Equity Inv2.03M1.32%159.48K
Vanguard Small Cap Index1.04M1.26%2.50K
Nuveen Quant Small Cap Equity R61.68M1.09%-
UBS (Lux) Digital Health Equity SB USD800.00K0.96%-370.00K
UBS Lux Dgtl Hlth Eq Fd seeding P acc800.00K0.96%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 03, 2026Parison Amy SVP, Chief Financial OfficerSell$1.75K
Jul 28, 2026Burkly Linda EVP, CHIEF SCIENTIFIC OFFICERSell$13.16K
Jun 03, 2026Parison Amy SVP, Chief Financial OfficerSell$1.25K
Jun 03, 2026O'Neill Gilmore Neil CEOSell$41.54K
Jun 03, 2026Burkly Linda EVP, CHIEF SCIENTIFIC OFFICERSell$1.97K

Insider Transactions Trends

DateBuySell
2026 Q3-2
2026 Q2-3
2026 Q1-3
2025 Q4-3
2025 Q3-5

EDIT Ownership FAQ

Who Owns Editas Medicine?

Editas Medicine shareholders are primarily institutional investors at 122.77%, followed by 0.18% insiders and -22.95% retail investors. The average institutional ownership in Editas Medicine's industry, Biotech Stocks , is 49.09%, which Editas Medicine exceeds.

Who owns the most shares of Editas Medicine?

Editas Medicine’s largest shareholders are Tcg crossover management (11.11M shares, 11.35%), Blackrock funding, inc. /de (10.59M shares, 10.82%), and Blackrock (7.78M shares, 9.50%). Together, they hold 31.67% of Editas Medicine’s total shares outstanding.

Does Blackrock own Editas Medicine?

Yes, BlackRock owns 9.50% of Editas Medicine, totaling 7.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.34M$. In the last quarter, BlackRock decreased its holdings by -50.264K shares, a -0.64% change.

Who is Editas Medicine’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Editas Medicine’s biggest shareholder by percentage of total assets invested, with 1.72% of its assets in 8.89M Editas Medicine shares, valued at 28.8M$.

Who is the top mutual fund holder of Editas Medicine shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Editas Medicine shares, with 3.19% of its total shares outstanding invested in 4.89M Editas Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools